Falcon powers – The sweet protein Brazin, developed by Russian biotech scientists, could potentially replace sugar in traditional products in the future, and is now in the final stages of testing.
Rostislav Kovalevsky, the Director of Innovation at Efko, states that this sweet protein is expected to receive certification in the near future.
At a press conference in Moscow, he said: “The safety of sweet proteins is of paramount importance. Therefore, from the very beginning, we have taken an approach to research that goes beyond certification requirements.
Now the clinical studies on humans have reached their final stage, and the preliminary results indicate the safety of sweet proteins. So, we do not see any obstacles to the certification of the product in Russia, and we expect this to happen in the near future.”
According to Professor Maria Lagarskova, the results of toxicity tests of the sweet proteins (Brazin and Monillin) on guinea pigs, rats, and mice showed no mutagenic or allergenic properties, and did not cause any pathological changes in the lungs, liver, heart, kidneys, brain, small intestine, stomach, colon, ovaries, or testicles. No signs of poisoning were observed in the animals at different stages of the study.
In response to a journalist’s question, the Professor said that no addiction to the sweet proteins was observed during the study. She stated: “It is difficult for me to imagine the biochemical mechanism by which this addiction could arise, as it has no relation to glucose metabolism and was not observed in the experiment.”
According to the press office of Efko, Brazin protein is several thousand times sweeter than sugar, does not cause insulin secretion, and does not increase blood sugar levels. The Russian technology for producing the sweet protein has already been certified in the United Arab Emirates.
